Literature DB >> 17014965

FoxM1: at the crossroads of ageing and cancer.

Jamila Laoukili1, Marie Stahl, René H Medema.   

Abstract

Forkhead transcription factors are intimately involved in the regulation of organismal development, cell differentiation and proliferation. Here we review the current knowledge of the role played by FoxM1 in these various processes. This particular member of the Forkhead family is broadly expressed in actively dividing cells and is crucial for cell cycle-dependent gene expression in the G2 phase of the cell cycle. FoxM1 plays a crucial role in insuring the fidelity of the cell division process, as inhibition of FoxM1 activity results in serious aberrancies during mitosis, such as frequent chromosome missegregation, defects in cytokinesis and overt aneuploidy. FoxM1 expression also appears to be tightly correlated with the proliferative rate of a cell. For example, FoxM1 is one of the most significantly down-regulated genes in prematurely aged human fibroblasts (Progeria syndrome), while elevated expression of FoxM1 is seen in most human carcinomas. These observations suggest that interference with FoxM1 activity may contribute to the increase in mitotic errors seen in human diseases such as cancer and early onset of ageing diseases. In this review, several aspects of FoxM1 function will be discussed, as well as their implication in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17014965     DOI: 10.1016/j.bbcan.2006.08.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  177 in total

1.  Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.

Authors:  Lizhu Jiang; Xiaosong Wu; Peng Wang; Taoyu Wen; Chao Yu; Lei Wei; Hongyan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-13       Impact factor: 4.553

2.  Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin.

Authors:  Vladimir Petrovic; Robert H Costa; Lester F Lau; Pradip Raychaudhuri; Angela L Tyner
Journal:  Cancer Biol Ther       Date:  2010-06-06       Impact factor: 4.742

3.  High Fat Diet Regulation of β-Cell Proliferation and β-Cell Mass.

Authors:  M L Golson; A Ackermann Misfeldt; U G Kopsombut; C P Petersen; M Gannon
Journal:  Open Endocrinol J       Date:  2010

4.  FoxM1 involvement in astrocyte proliferation after spinal cord injury in rats.

Authors:  Shuangwei Zhang; Honglin Teng; Qiulei Ding; Jinpeng Fan; Wanying Shi; Yan Zhou; Chunwu Zhang
Journal:  J Mol Neurosci       Date:  2013-02-06       Impact factor: 3.444

5.  NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS.

Authors:  Mitali Chattopadhyay; Ravinder Kodela; Gabriela Santiago; Thuy Tien C Le; Niharika Nath; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-02-14       Impact factor: 5.858

6.  Overexpression of FOXM1 as a target for malignant progression of esophageal squamous cell carcinoma.

Authors:  Liang Song; Xiaohang Wang; Zhen Feng
Journal:  Oncol Lett       Date:  2018-02-13       Impact factor: 2.967

7.  Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis.

Authors:  Hong Chen; Jingjing Wang; Hong Yang; Dan Chen; Panpan Li
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

Review 8.  Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis.

Authors:  J Jeffery; D Sinha; S Srihari; M Kalimutho; K K Khanna
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

9.  Hedgehog signaling pathway: the must, the maybe and the unknown.

Authors:  Paul Zarogoulidis; Katerina Zarampouka; Haidong Huang; Kaid Darwiche; Yong Huang; Antonis Sakkas; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

Review 10.  Fox transcription factors: from development to disease.

Authors:  Maria L Golson; Klaus H Kaestner
Journal:  Development       Date:  2016-12-15       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.